GB Patent

GB2105193A — Pharmaceutical compositions containing non-steroidal anti-inflammatory agents

Assigned to Glaxo Group Ltd · Expires 1983-03-23 · 43y expired

What this patent protects

The invention relates to a pharmaceutical composition comprising a systemic non-steroidal anti- inflammatory drug together with the histamine H2-antagonist ranitidine or a physiologically acceptable salt thereof. The histamine H2-antagonist reduces gastric mucosal lesions caused …

USPTO Abstract

The invention relates to a pharmaceutical composition comprising a systemic non-steroidal anti- inflammatory drug together with the histamine H2-antagonist ranitidine or a physiologically acceptable salt thereof. The histamine H2-antagonist reduces gastric mucosal lesions caused by the anti-inflammatory drug.

Drugs covered by this patent

Patent Metadata

Patent number
GB2105193A
Jurisdiction
GB
Classification
—
Expires
1983-03-23
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.